Modelling hepatitis C therapy--predicting effects of treatment
about
Bridging academic science and clinical research in the search for novel targeted anti-cancer agentsAnalysis of Practical Identifiability of a Viral Infection ModelModerate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies.Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies.Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.Shortening the duration of therapy for chronic hepatitis C infection.The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?Consolidation of molecular testing in clinical virology.Mathematical Models for Immunology: Current State of the Art and Future Research Directions.Modeling Viral Spread.Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients.Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor.Mathematical Analysis of Viral Replication Dynamics and Antiviral Treatment Strategies: From Basic Models to Age-Based Multi-Scale ModelingMathematical modeling of within-host Zika virus dynamicsSpecial Issue "Mathematical Modeling of Viral Infections"
P2860
Q26771396-94558BE4-F263-40A2-A3DD-5A7B42C17AFFQ36236319-74A86502-A371-424D-8AF1-DC47C954A792Q36497834-9B85A0CB-7C0F-4BBD-8750-92B284EC9597Q37721750-088A3FDC-FD9B-423C-8430-FA71A8DFE590Q38157172-673AD17D-6F6E-4E2F-8AD8-A94F8BDD3A03Q38375284-1AEB0D29-090C-4D00-B483-1BCFE9292510Q38627508-F4379483-3A79-4619-AF4B-0C6437544491Q38634755-6E345BC6-E83B-4B9E-8699-F8094E80AE33Q38779627-2CBF7DD5-D925-4BAD-8178-A6FF1F8CE1ADQ38809377-F8CB80AB-54E4-41DE-AB64-FAA483699ADEQ38952060-AA514B1B-CB5D-4BE9-99EE-90D3E82D7B6EQ39791929-41B3FD1F-4349-4F5F-9514-801530F11F8FQ47561388-06B1BD0C-8E0B-4414-BD7A-6A2B7AACC413Q56000943-9D9457D8-EAEF-4463-A9CF-A8111B02DF3DQ56336242-5C498BD2-08D8-414C-8170-2363EB712E39Q56479933-8B265B97-604D-4502-8357-E03D727974A0
P2860
Modelling hepatitis C therapy--predicting effects of treatment
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Modelling hepatitis C therapy--predicting effects of treatment
@ast
Modelling hepatitis C therapy--predicting effects of treatment
@en
Modelling hepatitis C therapy--predicting effects of treatment
@nl
type
label
Modelling hepatitis C therapy--predicting effects of treatment
@ast
Modelling hepatitis C therapy--predicting effects of treatment
@en
Modelling hepatitis C therapy--predicting effects of treatment
@nl
prefLabel
Modelling hepatitis C therapy--predicting effects of treatment
@ast
Modelling hepatitis C therapy--predicting effects of treatment
@en
Modelling hepatitis C therapy--predicting effects of treatment
@nl
P2860
P3181
P356
P1476
Modelling hepatitis C therapy--predicting effects of treatment
@en
P2860
P2888
P304
P3181
P356
10.1038/NRGASTRO.2015.97
P407
P577
2015-08-01T00:00:00Z
P6179
1039168540